{"id": "1355471870259122178", "creation": 1612004651.0, "user_id": "65890224", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#JohnsonandJohnson Announces Single-Shot #Janssen #COVID19 #Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 Trial - \nVaccine Candidate 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19,\u2026https://t.co/yVPy10RgUH", "first_save": 1634559108.199414, "hashtags": ["#JOHNSONANDJOHNSON", "#JANSSEN", "#COVID19", "#VACCINE"]}